02150nam a2200433 i 4500 260665 260665 ocn988946299 BD 20180426225221.0 m o d f cr bn||||a|||| 170605s2017 dcua ob f000 0 eng c PUCPR eng rda pn GPO GPO MvI pcc n-us--- Online KF26 .L277 2014 1043-C (online) Y 4.L 11/4:S.HRG.113-859 Y 4.L 11/4:S.HRG.113-859 United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Aging, author. Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014. Washington : U.S. Government Publishing Office, 2017. 1 online resource (iii, 65 pages) : illustrations. text txt rdacontent computer c rdamedia online resource cr rdacarrier S. hrg. ; 113-859 Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office. CRDP Program record. Includes bibliographical references. Description based on online resource, PDF version; title from title page (FDsys web site, viewed on June 5, 2017). Generic drugs Prices United States. Prescription pricing United States. Legislative hearings. lcgft Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Aging. Why are some generic drugs skyrocketing in price? (OCoLC)989729813 United States. Congress. Senate. S. hrg. ; 113-859. http://purl.fdlp.gov/GPO/gpo81355 sudocs 8 0 0 sudocs 0 0 7 7 55 2018-04-26 Federal Depository 0.00 0 Y 4.L 11/4:S.HRG.113-859 Y4L114SHRG11 2018-04-26 00:00:00 2018-04-26 8